% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Albert:825208,
      author       = {Albert, N. L. and Weller, M. and Suchorska, B. and
                      Galldiks, Norbert and Soffietti, R. and Kim, M. M. and La
                      Fugére, C. and Pope, W. and Law, I. and Arbizu, J. and
                      Chamberlain, M. and Vogelbaum, M. A. and Ellingson, B. M.
                      and Tonn, J. C.},
      title        = {{R}esponse {A}ssessment in {N}euro-{O}ncology ({RANO})
                      {W}orking {G}roup and {E}uropean {A}ssociation for
                      {N}euro-{O}ncology ({EANO}): {R}ecommendations for the
                      {C}linical {U}se of {PET} {I}maging in {G}liomas},
      journal      = {Neuro-Oncology},
      volume       = {18},
      number       = {9},
      issn         = {1522-8517},
      address      = {Oxford},
      publisher    = {Oxford Univ. Press},
      reportid     = {FZJ-2016-07679},
      pages        = {1199 - 1208},
      year         = {2016},
      abstract     = {This guideline provides recommendations for the use of PET
                      imaging in gliomas. The review examines established clinical
                      benefit in glioma patients of PET using glucose (18F-FDG)
                      and amino acid tracers (11C-MET, 18F-FET, and 18F-FDOPA). An
                      increasing number of studies have been published on PET
                      imaging in the setting of diagnosis, biopsy, and resection
                      as well radiotherapy planning, treatment monitoring, and
                      response assessment. Recommendations are based on evidence
                      generated from studies which validated PET findings by
                      histology or clinical course. This guideline emphasizes the
                      clinical value of PET imaging with superiority of amino acid
                      PET over glucose PET and provides a framework for the use of
                      PET to assist in the management of patients with gliomas.},
      cin          = {INM-3},
      ddc          = {610},
      cid          = {I:(DE-Juel1)INM-3-20090406},
      pnm          = {572 - (Dys-)function and Plasticity (POF3-572)},
      pid          = {G:(DE-HGF)POF3-572},
      typ          = {PUB:(DE-HGF)16},
      UT           = {WOS:000384005900008},
      pubmed       = {pmid:27106405},
      doi          = {10.1093/neuonc/now058},
      url          = {https://juser.fz-juelich.de/record/825208},
}